One of the main challenges in diagnosing Stage 0 is differentiating between benign and precancerous lesions. This requires a high level of expertise in histopathology and sometimes additional diagnostic tools. Another challenge is the potential for overdiagnosis, which can lead to unnecessary treatments and anxiety for patients.
